S
Sung Joo Kim
Researcher at Sungkyunkwan University
Publications - 203
Citations - 3670
Sung Joo Kim is an academic researcher from Sungkyunkwan University. The author has contributed to research in topics: Transplantation & Kidney transplantation. The author has an hindex of 31, co-authored 196 publications receiving 3078 citations. Previous affiliations of Sung Joo Kim include Naver Corporation & Samsung Medical Center.
Papers
More filters
Journal ArticleDOI
Expression of Heat Shock Protein 27 in Human Atherosclerotic Plaques and Increased Plasma Level of Heat Shock Protein 27 in Patients With Acute Coronary Syndrome
Haing Kee Park,Eui Chul Park,Sung Won Bae,Mi Young Park,Seon Woon Kim,Hwan-Soo Yoo,Munkhtsetseg Tudev,Young Hye Ko,Yoon-Ho Choi,Sung Joo Kim,Dong Ik Kim,Young-Wook Kim,Byung Boong Lee,Jong Bok Yoon,Jeong Euy Park +14 more
TL;DR: In the atherosclerotic lesion, Hsp27 expression is increased in the normal-appearing vessel adjacent to atherosclerosis plaque, whereas levels in the plaque itself are significantly decreased.
Journal ArticleDOI
Immunogenicity and Safety of the Adjuvanted Recombinant Zoster Vaccine in Chronically Immunosuppressed Adults Following Renal Transplant: A Phase 3, Randomized Clinical Trial.
Peter Vink,Josep Maria Ramon Torrell,Ana I. Sánchez Fructuoso,Sung Joo Kim,Sang Il Kim,Jeff Zaltzman,Fernanda Ortiz,Josep Maria Campistol Plana,A. Rodríguez,Henar Rebollo Rodrigo,Magda Campins Marti,Rafael Daroca Pérez,Francisco Manuel González Roncero,Deepali Kumar,Yang Jen Chiang,Karen Doucette,Lissa Pipeleers,Maria Luisa Agüera Morales,Maria Luisa Rodriguez-Ferrero,Antonio Secchi,Shelly A. McNeil,Laura Campora,Emmanuel Di Paolo,Mohamed El Idrissi,Marta López-Fauqued,Bruno Salaun,Thomas C. Heineman,Lidia Oostvogels +27 more
TL;DR: RZV was immunogenic in chronically immunosuppressed RT recipients and persisted above prevaccination baseline 12M post–dose 2, and gE-specific humoral and cell-mediated immune responses were higher in RZV than placebo recipients across postvaccination time points.
Journal ArticleDOI
Small molecule-mediated reprogramming of human hepatocytes into bipotent progenitor cells
Yohan Kim,Kyojin Kang,Seung Bum Lee,Daekwan Seo,Sangtae Yoon,Sung Joo Kim,Kiseok Jang,Yun Kyung Jung,Kyeong Geun Lee,Valentina M. Factor,Jaemin Jeong,Dongho Choi +11 more
TL;DR: This study is the first report of successful reprogramming of human hepatocytes to a population of proliferating bipotent cells with regenerative potential and provides a platform for personal and stem cell-based regenerative medicine.
Journal ArticleDOI
Hepatocyte transplantation for glycogen storage disease type Ib.
Kwang-Woong Lee,Ji-Hyun Lee,Sung Wook Shin,Sung Joo Kim,Jae-Won Joh,Doo-Hoon Lee,Jong-Won Kim,Hwa-Young Park,Soo-Youn Lee,H. H. Lee,J. W. Park,Shi-Yeon Kim,Hee-Hoon Yoon,Doo-Hee Jung,Yon Ho Choe,Suk-Koo Lee +15 more
TL;DR: In this study, hepatocyte transplantation allowed a normal diet in a patient with GSD-Ib, with substantial improvement in their quality of life, in what was the first and successful clinical hepatocytes transplantation in Korea.
Journal ArticleDOI
Safety of small-for-size grafts in adult-to-adult living donor liver transplantation using the right lobe.
Ju Ik Moon,Choon Hyuck David Kwon,Jae-Won Joh,Gum O Jung,Gyu-Seong Choi,Jae Berm Park,Jong Man Kim,Milljae Shin,Sung Joo Kim,Suk-Koo Lee +9 more
TL;DR: In conclusion, an SFSG (GRWR < 0.8%) can be used safely in adult‐to‐adult right lobe LDLT when a recipient is receiving the graft from a donor younger than 44 years old.